| Prev Close | 179.00 |
| Open | 178.81 |
| Day Low/High | 178.58 / 181.92 |
| 52 Wk Low/High | 112.60 / 187.67 |
| Volume | 990.03K |
McKesson Corporation (MCK)
180.85
1.85
1.03
NYSE
| Exchange | NYSE |
| Shares Outstanding | 160.56B |
| Market Cap | 28.89B |
| P/E Ratio | 13.98 |
| Div & Yield | N.A. (N.A) |
Latest News
McKesson Could Move Higher So Trade It From the Long Side
MCK is a Covid vaccine distribution play.
Jim Cramer: If the End of the Covid Era Is in Sight, Here Are the Stocks to Buy
I will come back to these names over and over again as we are now in the sweet spot for many.
Jim Cramer: Just How Will the Covid-19 Vaccines Be Distributed?
None of these questions have been answered which is why I see chaos ahead as we can't even imagine this process working.
Broadening Market Performance, the Vaccine 'Put', Trading McKesson
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
My Election Day Wish, Tech Sector Performance, Trading Amazon and 6 Other Stocks
Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.
Here's a Dividend Aristocrat Trading at a Discount
With 33 years of consecutive dividend increases, this health care name is a member of the Dividend Aristocrats Index.
4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine
Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?
Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook
Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.
Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon
Plus, reading tea leaves in the recent action in Apple and Salesforce.com.
Jim Cramer: It's Dangerous Down Here in the Trough
But that's exactly where we are right now, in this third day of the rotation, so here's your path to safety.
Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon
Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.
Forget the V-Shaped Bounce, Playing Lockheed Martin, Trading Thoughts
Expect more fiscal and monetary support and don't expect a full return to previous economic activity for quite some time.
Credit Suisse Endorses Packaged Foods Stocks This Morning
I recently endorsed the packaged foods goods sector and have purchased more Kraft Heinz , TreeHouse Foods and J. M. Smucker . (All three are on my Best Ideas List.) The stocks did quite well yesterday. Credit Suisse chimed in bullishly this morning ...
Takeaways From These Markets, Oil Is a Bear, Gambling on Tesla: Market Recon
I don't think any of the takeaways have to do with the political mess in Iowa, nor the 'State of the Union' address scheduled for Tuesday night.
Jim Cramer: Drug Stocks Are Too Cheap
These stocks are priced for total imperfection. That's just what you want.
Sussing the Fed -- Plus Apple, Amgen and Other Earnings: Market Recon
Markets are watching what Fed Chair Powell will signal for future rate cuts during this afternoon's FOMC rate decision.
McKesson Is Poised to Make a Significant Upside Breakout
Traders need to respect this price strength.
Jim Cramer: Here's Why the Market's So Feckless and Reactive
So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.
Fed Front and Center, Apple Earnings, Trading AMD: Market Recon
Understand that the expected Fed rate cut today is not about recent economic performance in the least.
Here Are 20 Companies to Watch for Dividend Increases This Week
We have more than 1,050 companies reporting quarterly earnings from Monday to Friday, and here are the ones to keep focus on.
Jim Cramer: What to Buy and What to Avoid on Trump's Latest China Tweet
As usual, the stocks that bounce back first are the tech stocks with little Chinese exposure and the consumer packaged goods that just demonstrated good numbers.
3 Top Healthcare Stocks Ripe For the Buying
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
McKesson or Cardinal Health: Which Is a Better Dividend Yield Buy?
Cardinal Health and McKesson have similar business models, but they are very different stocks.
Good Things Come to Those Who Wait
Undervalued shares can get even cheaper in the short run but eventually they play catch up, running much higher.
The Human Response Factor, Fed Moves, China Talks, MSFT Results: Market Recon
Many see the Fed as done for the year. Never assume. Read the words as they are written.
McKesson Hasn't Provided This Good a Value in a Decade
McKesson is a high-quality name with a very depressed valuation.
Time to Minimize Your Tax Bill With Tax-Loss Selling
Underwater positions on stocks you feel lukewarm about are prime candidates for tax selling.
